Related Stories


8 de mayo de 2023
Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…
Posted in: Parkinson

8 de mayo de 2023
The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…
Posted in: Parkinson

22 de julio de 2020
The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s…
Posted in: Parkinson, Uncategorised

8 de abril de 2020
An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija….
Posted in: Parkinson

2 de abril de 2020
Levodopa infusion pump We evaluate an ultraconcentrated levodopa administered subcutaneously in patients with motor fluctuations….
Posted in: Parkinson

11 de marzo de 2020
Our Unit has achieved to be activated in this outstanding project and so serious pathology….
Posted in: Parkinson
